Statistics for A finite course of peginterferon alfa-2a results in inactive chronic hepatitis b and hbsag clearance 5 years post-treatment in patients with hbeag-negative disease: Baseline characteristics and predictive factors of long-term response
Total visits
views | |
---|---|
A finite course of peginterferon alfa-2a results in inactive chronic hepatitis b and hbsag clearance 5 years post-treatment in patients with hbeag-negative disease: Baseline characteristics and predictive factors of long-term response | 0 |
Total visits per month
views | |
---|---|
March 2024 | 0 |
April 2024 | 0 |
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |